Transpire licenses PDE4 inhibitor for lung disease
04 Jun 2025 //
FIERCE BIOTECH
Transpire Bio Announces R&D and Manufacturing Expansion
06 May 2025 //
GLOBENEWSWIRE
Transpire Bio Begins New Study For Asthma And COPD Inhaled Drug
13 Jan 2025 //
GLOBENEWSWIRE
Transpire Bio Completes First Human Study in Asthma & COPD Program
17 Dec 2024 //
GLOBENEWSWIRE
Transpire Bio Announces Corporate Office Expansion
12 Nov 2024 //
GLOBENEWSWIRE
Transpire Bio Strengthens Leadership Team With New Appointments
15 Oct 2024 //
GLOBENEWSWIRE
Transpire Bio Doses First Human in Asthma Drug Program
01 Oct 2024 //
GLOBENEWSWIRE
Transpire Bio Inks Second Agreement with Recipharm
29 Sep 2022 //
CONTRACTPHARMA